Formulation Challenges for Delivery of RNA Therapies
Posted on 14/05/2020
The therapeutic potential of different forms of RNA has been studied since the 1990s resulting in the first regulatory approval at the end of that decade. Since then, several RNA-based therapeutics have been approved, mainly treating rare genetic or infectious diseases. One of the challenges for RNA therapeutics is their efficient and targeted delivery, and formulation is therefore crucial to their success.
This half-day webinar on 7th July will cover the different approaches used for RNA formulation, their application to molecules in clinical development, including for the treatment of Covid-19, as well as to marketed products. In addition to the presentations, there will be Technology Highlights from UK SMEs presenting novel approaches that may contribute to future RNA formulations. Speakers on the day include KTN’s Marcel Kuiper and Dr. Anna Blakney of Imperial College London.
After the presentations, there will be an opportunity for participants to meet their peers using 1:1 video chats.
13:30 – 14:00 Overview of RNA formulation
14:00 – 14:20 Academic RNA formulation presentation
14:20 – 14:40 Break
14:40 – 15:00 Technology Highlights by UK SMEs
15:00 – 15:30 Company RNA formulation presentation
15:30 – 17:00 1:1 participant video chats
This webinar has been organised by the Biopharmaceutical Formulation Group and is supported by the KTN’s Medicines Manufacturing Challenge Community.